Horizon Therapeutics News

After releasing slightly better-than-expected earnings earlier this week, Medtronic has gained attention from investors, pushing the stock higher by 5.5%. Medtronic is the world's largest medical technology firm, employing around 45,000 members of staff worldwide.

May 24, 2013 - Medtronic, Inc. , the world's leading medical technology company, today announced it will participate in the Sanford Bernstein 29 Annual Strategic Decisions Conference on Friday, May 31, 2013 in New York.

The firm currently has a "sector perform" rating on the stock. Other equities research analysts have also recently issued reports about the stock.

Replacing Degenerated Surgical Valves with CoreValve Results in Significant Hemodynamic Improvements for Patients MINNEAPOLIS - May 23, 2013 - Medtronic, Inc.

Presented at EuroPCR, One-Year Data from BELLO Study Show Durability of Clinical Results Following Treatment of De Novo Lesions with Novel Angioplasty Device PARIS -- May 23, 2013 -- One-year data from an Italian multicenter randomized controlled trial of the IN.PACT Falcon drug-eluting balloon from Medtronic, Inc.

Milestone Marks a Critical Step Forward in Bringing Renal Denervation to Patients in the U.S. MINNEAPOLIS - May 23, 2013 - Medtronic, Inc.

Medtronic, Inc. today said it would cut 2,000 jobs across the company as a result of "manufacturing consolidation efforts," while reporting that its Cardiac and Vascular Group, which includes operations in Santa Rosa, had worldwide sales of more than $2.3 billion for an increase of 5 percent over the year.

Medtronic Inc., the world's biggest maker of heart-rhythm devices, said fourth-quarter sales of pacemakers and defibrillators rose, surprising analysts who expected shrinking demand to continue.

The case involves cardiac resynchronization therapy devices, which deliver shocks to the heart if ventricles don't contract properly, and patents held by Mirowski Family Ventures.

Live On. Give On: Ten inspirational people will be awarded a $20,000 charitable donation and be honored at an awards celebration in Hawaii as part of the first annual Bakken Invitation MINNEAPOLIS - May 20, 2013- Medtronic, Inc.

Backed by Robust Clinical Data on Broad Product Family, New Thrombus Removal System Offers Superior Deliverability MINNEAPOLIS -- May 20, 2013 -- Expanding its portfolio of medical technology for the interventional treatment of cardiovascular disease, Medtronic, Inc.

May 14, 2013 - Medtronic, Inc. announced today it will report financial results for the fourth quarter and fiscal year 2013 on Tuesday, May 21, 2013.

May 10, 2013 - Data presented today at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions, show that Medtronic, Inc.

New Medtronic Data Show Additional Clinical Advantages in Pacing Both Ventricles Versus Conventional Right-Ventricular Pacing MINNEAPOLIS and DENVER - May 11, 2013 - Medtronic, Inc.

Medtronic : Data Show Medtronic-Exclusive LIA Software Detects Non-Medtronic Lead Issues at a Greater Rate Than Standard Impedance Monitoring Data presented today at Heart Rhythm 2013, the Heart Rhythm Society's 34^th Annual Scientific Sessions, show that Medtronic Lead Integrity Alert software detected pace/sense lead issues in non-Medtronic leads ... (more)

"Shock-Less" Late Breaking Clinical Trial: Providing Clinicians with ICD Programming Reports Improves Adherence to Evidence-Based Guidelines, Reduces All-Cause Shocks PainFree SST Trial: More Than 98 Percent of Patients with SmartShock Technology Are Free of Inappropriate Shock at One Year ADVANCE III Trial: Waiting to Deliver ICD Therapy Combined ... (more)

Cardiology device makers haven't had much good to report to investors lately. The entire medical device market has struggled with pricing pressures and other hurdles, but the headaches of heart devices -- from mature markets to Europe's financial crush -- have ramped up the pressure on industry firms such as Medtronic, Inc.

So that must mean corporate investors like Medtronic have the opportunity to swoop in and invest in promising early stage firms, correct? Well, not really says Chad Cornell, vice president of corporate development at Medtronic, who was a speaker at the annual IBF MedTech Investing Conference in Minneapolis Wednesday.

Newly designed Devices Result in Fewer Hospitalizations for Patients, Deliver Increased Longevity, and Improved Comfort MINNEAPOLIS - May 6, 2013 - Medtronic, Inc.

's stock had its "outperform" rating restated by analysts at BMO Capital Markets in a research report issued to clients and investors on Friday, AnalystRatingsNetwork reports.